John Deere partners with this tiny company

Today’s big movers inside                                                                                                                                                                                                                                                                                                                                                                                                                 April 23, 2024 | [Read Online]( John Deere partners with this tiny company In partnership with Good morning, 360! Don’t forget to join us today for LIVE trading in the [Market Master’s Room](. Friends don’t let friends trade alone! And see below for the Encore Webinar happening on Wednesday — please register! FOCUS LIST🔎 CYN - Up over 90% in the pre-market after announcing it has joined John Deere’s supply base KSCP - Up over 9% in pre after announcing 2 new contracts and new Autonomous Security Robot IBRX - Up over 25% in pre after receiving FDA approval for ANKTIVA® a Non-Muscle Invasive Bladder Cancer treatment *sponsored by Aura Health Two Forbes 30U30 Founders Transforming Mental Wellness Forbes 30 Under 30 winners founded [Aura]( to solve the $100B problem - mental wellbeing. Aura has quickly grown to 8 million users & 100k+ paying subscribers, and attracted investments from legendary Silicon Valley VCs & executives from Spotify, Facebook, and Apple. [The best part? You can invest now before the opportunity ends in a few days]([.]( HOTLIST🔥 CYN - Up over 90% in the pre-market after announcing it has joined John Deere’s supply base Cyngn (CYN) develops and deploys scalable, differentiated autonomous vehicle technology for industrial organizations. Cyngn's self-driving solutions allow existing workforces to increase productivity and efficiency. In the pre-market this morning, [CYN announced]( it had been chosen to supply its DriveMod Tuggers for industrial automation to John Deere's operation in Dubuque, Iowa. The stock traded up over 60% in the pre-market after the news. The $0.22 area acted as support in the pre-market and will be an important level to watch. Above it, targets to the upside are $0.24, $0.26, and then the pre-market high at $0.2869. Beyond that $0.30, $0.3149, and $0.36 come into play. Below $0.22, targets to the downside $0.20, $0.18, $0.16, $0.14 and then a gap fill at $0.1210. KSCP - Up over 9% in pre after announcing 2 new contracts and new Autonomous Security Robot Knightscope Inc. (KSCP) designs, develops, manufactures, markets, deploys, and supports autonomous security robots (ASR) in the United States. In the after-hours yesterday, the [company announced]( new Autonomous Security Robot ("ASR") and Blue Light Emergency Communication System sales along with 9 new deployments. The new sales and deployments are on the heels of the recently announced winning of 18 contracts valued over $1 million. The stock traded up over 9% in the pre-market after the news. The first target for bulls is the pre-market high at $0.4819. Beyond that $0.50, $0.55, $0.60, $0.63 and $0.70 come into play. Below $0.4819, targets to the downside are $0.45, a gap fill at $0.43 and then $0.41. Special Encore 👏 **sponsored by TheoTrade See why Mr. Kaufman of Think or Swim fame, is one of industry's LEADING financial strategists and educational authorities. LIVE Encore Webinar Wed, April 24th @12pm EST [REGISTER FOR LUNCH WITH MR. KAUFMAN!]( IBRX - Up over 25% in pre after receiving FDA approval for ANKTIVA® a Non-Muscle Invasive Bladder Cancer treatment ImmunityBio Inc. (IBIO) is a clinical-stage biotechnology company that engages in discovering, developing, and commercializing next-generation immuno- and cellular therapies for cancer and infectious diseases in the United States and Europe. In the after-hours yesterday, the [company announced]( that it had received FDA approval for ANKTIVA® a Non-Muscle Invasive Bladder Cancer treatment/ ANKTIVA is now designated an FDA Breakthrough Therapy, the novel immunotherapy ANKTIVA activates the body’s natural killer (NK) and killer T-cell immune system to attack tumor cells. The percentage of patients with durable responses at 12 and 24 months exceeded the benchmark for magnitude of clinically meaningful results established by experts at the International Bladder Cancer Group (IBCG). ANKTIVA is expected to be available in the U.S. by mid-May 2024. IBRX traded up over 20% in the pre-market in reaction to the results. The $6 area was resistance in the after-hours and acted as support in the pre-market. Above it, targets to the upside are $6.25, $6.50, $6.60, $6.75 and then the pre-market high at $6.98. Below $6, targets to the downside are $5.80, $5.70, $5.40, $5.20 and then a gap fill at $4.94. MARKET NEWS 📰 MORE Great Trading Resources: [Get instant access to Jeff Bishop's top trading ideas]( [For great training in options basics, start your journey Jeff Williams]( 💡[Get the hottest stock ideas in Bright Ideas]( Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. *ISSUER-PAID ADVERTISEMENT: This Issuer has paid RagingBull.com, LLC (“Raging Bull”) fifteen thousand five hundred dollars in total to run advertisements enhancing public awareness of the company. RagingBull is currently an Affiliate for Aura Health. If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals. **Sponsored Content: We’re a proud affiliate for TheoTrade, meaning if you click a link for a product or service, we may earn a commission at no extra cost to you. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers mentioned in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. [tw]( Update your email preferences or unsubscribe [here]( © 2024 360 WallStreet 62 Calef Hwy. #233 lee, NH 03861, United States of America